Etalocib (LY293111)
目录号: A22473
leukotriene B4 receptor 拮抗剂
Etalocib,也被称为LY293111和VML295,是一种强效且选择性的抑制剂,它通过直接抑制5'-脂氧合酶或通过拮抗白三烯B4 (LTB4) 受体来抑制脂氧合酶途径。
leukotriene B4 receptor 拮抗剂
| Discription | Etalocib, also known as LY293111 and VML295, is a potent and selective inhibitor of the lipoxygenase pathway either directly through 5'-lipoxygenase or via antagonism of the leukotriene B4 (LTB4) receptor. |
|---|
| 目录号 | A22473 |
|---|---|
| 分子式 | C33H32FNaO6 |
| 分子量 | 566.59 |
| CAS号 | 161172-51-6 |
| SMILES | O=C([O-])C1=CC=CC=C1OC2=CC=CC(OCCCOC3=C(CC)C=C(C4=CC=C(F)C=C4)C(O)=C3)=C2CCC.[Na+] |
| 其他名称 | VML295, VML-295, VML 295, LY293111, LY-293111, LY 293111, PDSP1001237, PDSP2001221, Etalocib |
| 储存条件 | Store lyophilized at -20ºC, keep desiccated. |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2